Understanding how alcohol use affects people living with HIV
Biomarkers for Alcohol/HIV Research (BAHR) Study
This study is looking at how drinking alcohol affects people living with HIV, especially how it influences their ability to stick to their medication and their overall health, using a special test to get accurate information about alcohol use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10791785 on NIH RePORTER |
What this research studies
This research investigates the impact of alcohol consumption on individuals living with HIV, focusing on how it affects their adherence to antiretroviral therapy and overall health outcomes. By utilizing objective biomarkers, specifically phosphatidylethanol (PEth), the study aims to accurately measure alcohol use over the past few weeks, addressing the limitations of self-reported data. The study will pool data from over 8,000 participants to clarify the relationship between alcohol use and HIV-related health issues, providing a comprehensive analysis of the effects of alcohol on this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who consume alcohol.
Not a fit: Patients who do not consume alcohol or are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for people living with HIV by identifying safe levels of alcohol consumption and effective interventions.
How similar studies have performed: Previous research has shown promise in using biomarkers like PEth to assess alcohol consumption, indicating that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hahn, Judith Alissa — University of California, San Francisco
- Study coordinator: Hahn, Judith Alissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.